Jim Simons Renaissance Technologies
AUM
$75.2B
1-Year Return
41.49%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Quarter Return
+11.58%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$130B
AUM Growth
+$12B
(+10%)
Cap. Flow
+$3.31B
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
12.68%
Holding
3,913
New
518
Increased
1,840
Reduced
1,085
Closed
444
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76B |
| 2 |
Tesla
TSLA
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$623M |
| 4 |
AbbVie
ABBV
|
+$398M |
| 5 |
Qualcomm
QCOM
|
+$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$603M |
| 3 |
Micron Technology
MU
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$365M |
| 5 |
UnitedHealth
UNH
|
+$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Vanda Pharmaceuticals
VNDA
$272M
| $56.7M | 0.04% |
3,453,112
+244,772
| +8% | +$4.02M |
|
477
Alaska Air
ALK
$7.36B
| $56.4M | 0.04% |
832,327
+665,427
| +399% | +$45.1M |
|
|
GOOD
478
Gladstone Commercial Corp
GOOD
$610M
| $56.3M | 0.04% |
2,573,300
-20,700
| -0.8% | -$452K |
|
479
Ormat Technologies
ORA
$5.56B
| $56.2M | 0.04% |
754,700
-90,700
| -11% | -$6.76M |
|
480
SEI Investments
SEIC
$10.9B
| $56M | 0.04% |
855,400
-124,026
| -13% | -$8.12M |
|
|
NXRT
481
NexPoint Residential Trust
NXRT
$870M
| $56M | 0.04% |
1,243,500
| – | – |
|
482
Malibu Boats
MBUU
$652M
| $55.9M | 0.04% |
1,364,201
+142,900
| +12% | +$5.85M |
|
483
Murphy USA
MUSA
$7.59B
| $55.7M | 0.04% |
475,800
+92,500
| +24% | +$10.8M |
|
484
FNB Corp
FNB
$5.9B
| $55.7M | 0.04% |
4,383,328
+722,000
| +20% | +$9.17M |
|
485
Trane Technologies
TT
$92.3B
| $55.6M | 0.04% |
418,168
+169,903
| +68% | +$22.6M |
|
486
RB Global
RBA
$22B
| $55.4M | 0.04% |
1,288,897
+530,997
| +70% | +$22.8M |
|
487
Manhattan Associates
MANH
$13.3B
| $55.3M | 0.04% |
692,980
+331,020
| +91% | +$26.4M |
|
|
MODV
488
DELISTED
ModivCare
MODV
| $55.1M | 0.04% |
930,699
-32,621
| -3% | -$1.93M |
|
489
Check Point Software Technologies
CHKP
$21.1B
| $54.9M | 0.04% |
495,183
+413,583
| +507% | +$45.9M |
|
490
Clearway Energy Class C
CWEN
$3.37B
| $54.9M | 0.04% |
2,750,775
+363,997
| +15% | +$7.26M |
|
|
IMGN
491
DELISTED
Immunogen Inc
IMGN
| $54.7M | 0.04% |
10,707,139
+2,184,100
| +26% | +$11.1M |
|
492
Methanex
MEOH
$3.08B
| $54.5M | 0.04% |
1,410,348
+332,600
| +31% | +$12.8M |
|
493
Enphase Energy
ENPH
$4.88B
| $54.3M | 0.04% |
2,078,857
+1,956,157
| +1,594% | +$51.1M |
|
|
TARO
494
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $54.2M | 0.04% |
616,400
+34,700
| +6% | +$3.05M |
|
495
Par Pacific Holdings
PARR
$1.71B
| $54.1M | 0.04% |
2,326,447
+611,847
| +36% | +$14.2M |
|
496
American Financial Group
AFG
$11.7B
| $53.9M | 0.04% |
491,809
-299,106
| -38% | -$32.8M |
|
497
TIM SA
TIMB
$10.1B
| $53.9M | 0.04% |
2,821,298
-1,259,726
| -31% | -$24.1M |
|
498
Eversource Energy
ES
$24.1B
| $53.5M | 0.04% |
629,249
-1,224,222
| -66% | -$104M |
|
499
Ecolab
ECL
$78B
| $53.4M | 0.04% |
+276,922
| New | +$53.4M |
|
|
LMNX
500
DELISTED
Luminex Corp
LMNX
| $53.2M | 0.04% |
2,295,442
+74,700
| +3% | +$1.73M |
|